BMC biology · 2025
A lethal DENV-2 wild-type mouse model for mutagenesis investigations.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Qin Zhiran, Xie Xiaoting, Ye Hua, Wu Hao, Li Zhuoyun, Li Jingshu, He Xiaoen, Liang Zuxin, Liu Xuling, Zhu Li, Wu Qinghua, Xiao Weiwei, Wu Kefeng, Wan Chengsong, Zhang Bao, Sun Zhaohui, Yu Jianhai, Shen Chenguang, Yu Linzhong, Zhao Wei
Аннотация
BACKGROUND: Effective mouse models for testing antiviral medications should be both cost-effective and require minimal labor. Immunodeficient mouse models, such as AG129, are commonly used in dengue virus (DENV) research; however, their high import and maintenance costs make them relatively expensive. Moreover, the absence of IFN-γ signaling limits the capacity of the AG129 model. To date, wild-type mouse models of DENV infection have only exhibited mild symptoms without lethality, limiting their research applicability. In this study, we developed a lethal C57BL/6 wild-type mouse model infected with DENV-2 365 strain. By blocking the type I interferon receptor before the virus challenge, we allowed the immune response to be restored at a later stage of infection.
RESULTS: Following infection, the mice exhibited severe symptoms, including weight loss, high viremia levels, elevated inflammatory cytokines, significant vascular leakage, and pathological changes in the brain, kidney, liver and spleen. The model also displayed severe central nervous symptoms and 100% mortality. Additionally, we used this model to evaluate an adaptable NS2A protein mutation found in both Zika virus and DENV-2.
CONCLUSIONS: Our study introduces an alternative model design for investigating viral mutations, providing a valuable tool for future research.
RESULTS: Following infection, the mice exhibited severe symptoms, including weight loss, high viremia levels, elevated inflammatory cytokines, significant vascular leakage, and pathological changes in the brain, kidney, liver and spleen. The model also displayed severe central nervous symptoms and 100% mortality. Additionally, we used this model to evaluate an adaptable NS2A protein mutation found in both Zika virus and DENV-2.
CONCLUSIONS: Our study introduces an alternative model design for investigating viral mutations, providing a valuable tool for future research.